This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
NAMBI, VIJAY
| Item Type | Name |
|
Academic Article
|
Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice.
|
|
Academic Article
|
Barriers to non-HDL cholesterol goal attainment by providers.
|
|
Academic Article
|
Association between traditional cholesterol parameters, lipoprotein particle concentration, novel biomarkers and carotid plaques in retired National Football League players.
|
|
Academic Article
|
Lipid management: considerations in acute coronary syndrome.
|
|
Academic Article
|
Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the Atherosclerosis Risk in Communities study.
|
|
Academic Article
|
Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study.
|
|
Academic Article
|
ASCOT-LLA and the primary prevention of coronary artery disease in hypertensive patients.
|
|
Academic Article
|
Combination therapy with statins and omega-3 fatty acids.
|
|
Academic Article
|
Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study.
|
|
Concept
|
Receptors, LDL
|
|
Concept
|
Lipoproteins, LDL
|
|
Concept
|
Cholesterol, LDL
|
|
Academic Article
|
The role of antisense oligonucleotide therapy in patients with familial hypercholesterolemia: risks, benefits, and management recommendations.
|
|
Academic Article
|
Obesity, subclinical myocardial injury, and incident heart failure.
|
|
Academic Article
|
Advances in the management of dyslipidemia.
|
|
Academic Article
|
Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease.
|
|
Academic Article
|
Case reports of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition nonresponse.
|
|
Academic Article
|
Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial.
|
|
Academic Article
|
ApoB, small-dense LDL-C, Lp(a), LpPLA2 activity, and cognitive change.
|
|
Academic Article
|
Impact of Lipid Monitoring on Treatment Intensification of Cholesterol Lowering Therapies (from the Veterans Affairs Healthcare System).
|
|
Academic Article
|
Low-density lipoprotein cholesterol goals in the secondary prevention of cardiovascular diseases in the Indian population-Is 30 the new 70?
|
|
Academic Article
|
Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH).
|
|
Academic Article
|
Association of patient, provider and facility related characteristics with statin associated side effects and statin use: Insight from the Veteran's Affairs healthcare system.
|
|
Academic Article
|
Association of PCSK9 Variants With the Risk of Atherosclerotic Cardiovascular Disease and Variable Responses to PCSK9 Inhibitor Therapy.
|
|
Academic Article
|
Midlife determinants of healthy cardiovascular aging: The Atherosclerosis Risk in Communities (ARIC) study.
|
|
Academic Article
|
LDL-C Lowering in Prevention of Atherosclerotic Cardiovascular Disease: Another Step Forward in This Lifelong Marathon.
|